Bg pattern

ESBERIVEN 100 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ESBERIVEN 100 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

PROSPECTO: INFORMACIÓN PARA EL USUARIO

ESBERIVEN 100 mg/ml solución oral

Troxerutina

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto.

Contenido del prospecto:

  1. Qué es Esberiven y para qué se utiliza.
  2. Qué necesita saber antes de empezar a tomar Esberiven.
  3. Cómo tomar Esberiven.
  4. Posibles efectos adversos.
  5. Conservación de Esberiven.
  6. Contenido del envase e información adicional.

1. Qué es Esberiven y para qué se utiliza

Esberiven pertenece al grupo de los medicamentos protectores de los capilares.

Está indicado en el a livio a corto plazo (durante dos-tres meses) del edema y síntomas relacionados con la insuficiencia venosa crónica, tales como: sensación de piernas pesadas, dolorosas e hinchadas.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Esberiven

No tome Esberiven

  • Si es alérgico a troxerutina o a cualquiera de los demás componentes de este medicamento (incluidos en la sección 6).

Advertencias y precauciones

Tenga especial cuidado con Esberiven.

  • Si padece o ha padecido úlcera gástrica o duodenal, hemorragia grave o disminución del número de las plaquetas (células sanguíneas que intervienen en los procesos de coagulación de la sangre).

Consulte a su médico o farmacéutico antes de empezar a tomar Esberiven.

Uso de Esberiven con otros medicamentos

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o podría tener que tomar cualquier otro medicamento, incluso los adquiridos sin receta médica.

No se conocen interacciones con otros medicamentos.

Uso de Esberivencon alimentos

No se conocen interacciones con los alimentos.

Embarazo, lactancia y fertilidad

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

Embarazo

No hay experiencia apropiada acerca de la seguridad de Esberiven en el embarazo. Su utilización en mujeres gestantes se realizará, siempre, sopesando la relación entre el beneficio aportado y el posible riesgo de su administración.

Lactancia

Troxerutina no pasa a la leche materna en cantidades significativas. No se han descrito efectos perjudiciales para el niño lactante.

Conducción y uso de máquinas

No afecta a la capacidad para conducir y usar maquinaria.

Esberiven 100 mg/ml solución oral contiene parahidroxibenzoato de metilo (E-218) y parahidroxibenzoato de propilo (E-216)

Puede producir reacciones alérgicas (posiblemente retardadas) y, excepcionalmente broncoespasmo (sensación repentina de ahogo) porque contiene parahidroxibenzoato de metilo (E-218) y parahidroxibenzoato de propilo (E-216).

3. Cómo tomar Esberiven

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Este medicamento se administra por vía oral.

Adultos:

La dosis recomendada es de 10 mililitros al día, en una toma de 10 ml o en dos tomas de 5 ml.

Este medicamento puede tomarse mezclado con un poco de leche fría con o sin azúcar, zumo o refresco de frutas o agua azucarada.

Si toma más Esberiven del que debe

Pueden aparecer náuseas o vómitos y dolor de estómago. En caso de sobredosis o ingestión accidental consulte inmediatamente a su médico o farmacéutico o llame al Servicio de Información Toxicológica, teléfono 91 562 04 20, indicando el medicamento y la cantidad ingerida.

Si olvidó tomar Esberiven

No tome una dosis doble para compensar las dosis olvidadas.

Si interrumpe el tratamiento con Esberiven

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, Esberiven puede producir efectos adversos, aunque no todas las personas los sufran.

Los efectos adversos de Esberiven son generalmente infrecuentes, leves y transitorios.

Las reacciones adversas que se han observado son:

Trastornos gastrointestinales:molestias abdominales, dispepsia (digestión pesada, ardor y acidez), náuseas.

Trastornos del tejido de la piel y del tejido subcutáneo:erupción cutánea.

Trastornos del sistema nervioso:cefalea.

Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto.

5. Conservación de Esberiven

Mantener fuera de la vista y del alcance de los niños.

No se requieren condiciones especiales de conservación.

No utilice este medicamento después de la fecha de caducidad que aparece en la caja después de CAD. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Esberiven100 mg/ml solución oral

  • El principio activo es troxerutina. Cada 10 ml de la solución oral contienen 1 g de troxerutina, como principio activo.
  • Los demás componentes son: propilenglicol, parahidroxibenzoato de metilo (E218), parahidroxibenzoato de propilo (E216), sorbato de potasio (E202), sacarina de sodio, aroma caramelo y agua purificada.

Aspecto del producto y contenido del envase

Esberivenes una solución oral, trasparente y de color amarillo intenso que se presenta en frasco de vidrio topacio, con tapón de polipropileno/polietileno de alta densidad (PP/HDPE) con cierre a prueba de niños (Child-Proof), que contiene 200 ml de solución acompañado de un vaso dosificador.

Titular de la autorización de comercialización

Faes Farma, S.A.

Autonomia Etorbidea, 10

48940 Leioa (Bizkaia)

España

Responsable de la fabricación

Faes Farma, S.A.

Parque Científico y Tecnológico de Bizkaia

Ibaizabal Bidea, Edificio 901

48160 Derio (Bizkaia)

España

Fecha de la última revisión de este prospecto:Diciembre 2004

La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

Online doctors for ESBERIVEN 100 mg/ml ORAL SOLUTION

Discuss questions about ESBERIVEN 100 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ESBERIVEN 100 mg/ml ORAL SOLUTION?
ESBERIVEN 100 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ESBERIVEN 100 mg/ml ORAL SOLUTION?
The active ingredient in ESBERIVEN 100 mg/ml ORAL SOLUTION is troxerutin. This information helps identify medicines with the same composition but different brand names.
Who manufactures ESBERIVEN 100 mg/ml ORAL SOLUTION?
ESBERIVEN 100 mg/ml ORAL SOLUTION is manufactured by Faes Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ESBERIVEN 100 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ESBERIVEN 100 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ESBERIVEN 100 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (troxerutin) include TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION, VARILIV TROXERUTINE 1 g ORAL SOLUTION GRANULES, VENORUTON OXERUTINES 1 g ORAL SOLUTION POWDER. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media